Introduction {#s1}
============

The complement of genes expressed in an individual cell type controls its identity, development, and function. While transcriptional regulation is a major component of gene expression, post-transcriptional regulation can further shape cellular attributes by, for example, determining which gene isoforms are expressed in a cell. Much recent work has gone into cataloging gene expression networks in single cells, particularly those of specific neuronal types ([@bib39]; [@bib46]). Molecular studies have also identified mechanisms by which transcription factors (TFs) shape gene expression networks in single neurons. Due to technical limitations, less is known about post-transcriptional regulation at the level of single neurons, or about the RNA binding proteins (RBPs) mediating post-transcriptional regulation ([@bib10]).

It is also unknown to what extent transcriptional and post-transcriptional gene regulatory networks are coordinated in single cells. A number of studies have identified individual RBPs that affect the splicing of a TF, thus altering the activity or specificity of that TF ([@bib3]; [@bib11]; [@bib21]; [@bib33]). These results suggest that there may be extensive cross-talk between transcriptional and post-transcriptional regulatory layers.

The nematode *Caenorhabditis elegans* has been used extensively as a model to reveal underlying principles by which TFs shape the transcriptomes of individual neurons. The worm's invariant cell lineage, coupled with genetic tools and a transparent body, enables systematic in vivo analysis of gene expression in single neurons, and identification of TFs responsible for cell-specific gene expression. This type of analysis has revealed a number of gene regulatory principles, including the concept of a 'combinatorial code' of TFs which can be re-used in different neuron types, with particular combinations of TFs determining specific cell fates ([@bib8]; [@bib9]; [@bib31]). Another example is the concept of 'phenotypic convergence' by which various neurons express similar gene networks but the TFs driving the networks are different for each neuron type ([@bib8]; [@bib31]). These principles appear to apply to the nervous systems of other organisms as well ([@bib18]). However, it remains unknown whether similar mechanistic principles apply to post-transcriptional regulation by RBPs in the nervous system.

Here we use single-cell in vivo fluorescent splicing reporters to investigate the cell-specific splicing of *sad-1*, a conserved neuronal kinase. The *C. elegans sad-1* gene encodes two isoforms that differ in their ability to interact with the F-actin binding protein NAB-1/Neurabin ([@bib14]), and have different roles in synapse formation and development ([@bib16]). We find that *sad-1* undergoes unique splicing patterns in various neuron types, and that developmentally-related cell types (the ALM touch-sensing neuron and the BDU neuron) exhibit opposing patterns of splicing (exon inclusion vs. exon skipping). A combination of unbiased genetic screens and candidate targeted mutations identified a cascade of three cell-fate determining TFs and two neuronal RBPs required for proper splicing of *sad-1* in ALM neurons. Mechanistic dissection revealed that the three TFs function to establish cell-specific expression of the two RBPs in the ALM neuron, and that the two RBPs in turn directly bind to *sad-1* intronic regions to mediate exon inclusion in the ALM neuron. Finally, we find that in other neuron types, similar principles apply but with different combinations of TFs and RBPs mediating *sad-1* exon inclusion. These results indicate that neuronal RBPs, like TFs, are employed in a combinatorial code to shape neuron-specific splicing patterns, and demonstrate phenotypic convergence by which different RBPs mediate similar splicing outcomes in various neurons.

Results {#s2}
=======

Alternative splicing of the neuronal kinase *sad-1* in specific cell types {#s2-1}
--------------------------------------------------------------------------

To identify alternative splicing regulation in individual neuronal cell types, we created two-color splicing reporters that provide a fluorescent readout of splicing regulation in vivo in single cells ([@bib20]; [@bib30]). A minigene representing an alternative splicing event of interest is cloned upstream of a dual GFP/RFP cassette ([Figure 1A--B](#fig1){ref-type="fig"}). The GFP and RFP coding sequences reside in alternative reading frames. The alternative exon is engineered to shift the reading frame by +1 nucleotide such that splicing of the alternative exon determines the reading frame, and therefore the translation of GFP versus RFP. Application of two-color fluorescent reporters to transparent organisms such as *C. elegans* enables in vivo imaging of alternative splicing in individual cells. We have created reporters for splicing events in a number of neuronal genes, and uncovered a rich variety of splicing patterns in single neurons ([@bib26]).

![*sad-1* is alternatively spliced in single neurons.\
(**A**) The *sad-1* gene. Alternative cassette exon in blue. (**B**) Two-color splicing reporter schematic for *sad-1* cassette exon. The cassette exon encodes a + 1 nt frameshift so that when skipped, GFP is produced with an in frame stop codon. When skipped, GFP is read out of frame without stop codons, followed by in-frame translation of RFP. (**C**) Whole worm fluorescent micrograph demonstrating both exon inclusion (RFP) and skipping (GFP) in many neurons, while certain neurons express only the included (ALM) of skipped (BDU) isoforms. (**D--E**) Higher magnification focusing on ALM and BDU neurons. (**F**) BDU and ALM are both paired neurons present on the left and right side of the worm. Each BDU neuron is a sister cell to an ALM neuron, derived from the same neuroblast. Scale bar represents 10 µm.](elife-46726-fig1){#fig1}

One intriguing example of neuron-specific alternative splicing is in the conserved neuronal kinase *sad-1*, which plays important roles in neuronal development in both worms and mice ([@bib15]; [@bib17]). In *C. elegans, sad-1* is encoded by seventeen exons, and the fifteenth exon is an alternative cassette-type exon ([Figure 1A](#fig1){ref-type="fig"}). Alternative splicing of this exon changes the coding sequence and length of the *sad-1* C-terminus ([@bib16]). This presents an interesting parallel with mice and human genomes, which encode two separate genes homologous to *sad-1* (SAD-A and SAD-B) that are nearly identical except for their C-terminal coding sequence and length.

A two-color splicing reporter for *sad-1* in *C. elegans* revealed that many neurons express both the skipped and included isoforms ([Figure 1C](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). For example, motor neurons in the ventral nerve cord express both isoforms of *sad-1* ([Figure 1C](#fig1){ref-type="fig"}). On the other hand, the ALM touch-sensing neuron expresses only the included isoform, while the BDU neuron, which is the sister cell to the ALM neuron, expresses only the skipped isoform ([Figure 1C--F](#fig1){ref-type="fig"}). While different neurons exhibit differences in *sad-1* splicing, the splicing pattern in a given neuron is reproducible and invariant from one animal to the next, suggesting that *sad-1* splicing in various neurons is under strict regulatory control. These results led us to ask how ALM and BDU neurons, which are developmentally related ([Figure 1F](#fig1){ref-type="fig"}) and share a number of anatomical and gene-expression features, specify opposite splicing regimes.

Forward genetic screen identifies a trio of fate-determining TFs affecting *sad-1* splicing in the ALM neuron {#s2-2}
-------------------------------------------------------------------------------------------------------------

To identify regulators of *sad-1* splicing in the ALM touch neuron, we performed an unbiased forward genetic screen. Parental worms harboring the *sad-1* splicing reporter were mutagenized with EMS. We then screened for F~2~ animals (potential homozygotes) with aberrant expression of the skipped (GFP) isoform in the ALM neuron ([Figure 2A](#fig2){ref-type="fig"}). This screen identified three distinct loci that transform the splicing pattern from the ALM neuron pattern (full exon inclusion) to resemble the pattern in their BDU sister cells (full exon skipping).

![Genetic screen identifies neuronal TFs affecting *sad-1* splicing in the ALM neuron.\
(**A**) Schematic of forward genetic screen to identify regulators of *sad-1* splicing in the ALM touch neuron. (**B--F**) ALM neurons (dashed boxes) shift from complete inclusion (RFP) to skipping (GFP) in *unc-86(e1416)*, *mec-3(e1338)*, or *alr-1(oy42)* TF mutants. Splicing phenotypes fully penetrant (n = 50 animals) (**G**) Previously-identified roles of the three TFs in a transcriptional cascade to control touch neuron gene expression. Scale bar represents 10 µm.](elife-46726-fig2){#fig2}

Whole-genome resequencing of the mutant strains identified loss-of-function mutations in three conserved TFs: *unc-86, mec-3*, and *alr-1* ([Figure 2B--F](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). All three genes have previously been identified as key regulators of touch-neuron cell fate ([@bib9]; [@bib40]). The three TFs function in a transcriptional cascade ensuring cell-specific expression of *mec-3* in touch neurons, which then results in expression of a battery of touch-neuron specific genes ([Figure 2G](#fig2){ref-type="fig"}). Loss of the TF *mec-3* results in touch neurons (ALMs) adopting certain gene-expression characteristics of their sister cells (BDUs) ([@bib9]), mirroring our observation that loss of *mec-3* transforms *sad-1* splicing from an ALM (exon 15 included) to a BDU (exon 15 skipped) pattern.

Previous work demonstrates that the MEC-3 TF is expressed only in touch neurons, while UNC-86 and ALR-1 are expressed in various neuron types ([@bib40]). However, we find that *unc-86* and *alr-1* mutants affect *sad-1* splicing only in the touch neurons ([Figure 2D--F](#fig2){ref-type="fig"}). This is in accordance with previous work indicating that a major function of *unc-86* and *alr-1* in touch neurons is to combinatorially ensure appropriate expression of *mec-3*, and that all three TFs are needed for proper differentiation of touch neurons ([@bib40]). We therefore conclude that the combinatorial activity of all three TFs is required for proper *sad-1* splicing in the ALM neuron.

A pair of RNA binding proteins regulates *sad-1* splicing in the ALM neuron {#s2-3}
---------------------------------------------------------------------------

We were surprised to identify TFs, but not RBPs, in our forward genetic screen for regulators of *sad-1* alternative splicing. We hypothesized that multiple RBPs might co-regulate *sad-1* alternative splicing in the ALM neuron and therefore mutations in individual RBPs might result in mild splicing defects. We therefore examined the sequence surrounding the *sad-1* alternative exon for conserved *cis*-elements corresponding to known in vitro RBP sequence preferences ([@bib34]). We identified three candidate elements: one corresponding to the *mbl-1/*Mbnl1 consensus binding motif, and two corresponding to the *mec-8/RBMS* motif ([Figure 3A--C](#fig3){ref-type="fig"}).

![Two neuronal RBPs combinatorially control *sad-1* splicing in ALM neurons.\
(**A**) Conservation scores in the introns surrounding *sad-1* exon 15, basewise phyloP26way comparison of 26 nematode species ([@bib13]). Numbers 1--3 indicate consensus binding motifs for *mbl-1* and *mec-8* displayed in B-C. (**B--C**) *cis-*elements matching consensus binding motifs for *mbl-1* and *mec-8*. (**D--F**) *mec-8* and *mbl-1* mutants both cause a partial loss of *sad-1* exon inclusion. (**G**) *mec-8; mbl-1* double mutants cause complete loss of exon inclusion, phenocopying the TF mutants. Splicing phenotypes fully penetrant (n = 50 animals) Scale bar represents 10 µm.](elife-46726-fig3){#fig3}

To test whether these RBPs affect *sad-1* alternative splicing, we created deletions for each gene with CRISPR/Cas9 ([@bib28]). Both *mec-8* and *mbl-1* mutants result in aberrant *sad-1* splicing in the ALM neuron, displaying partial skipping and partial inclusion ([Figure 3D--F](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). As in the case of the TF mutants, *mec-8* mutants affect *sad-1* splicing specifically in the ALM neurons, whereas *mbl-1* mutants affect *sad-1* splicing in ALM neurons as well as specific neurons in the ventral nerve cord (see Figure 6, below). To verify that the phenotypes of our CRISPR mutants were on-target effects, we crossed the *sad-1* splicing reporter into existing alleles for *mec-8* (*e398*, premature stop codon \[[@bib6]; [@bib22]\]) and *mbl-1* (*wy560,* large deletion affecting multiple genes including *mbl-1* \[[@bib38]\]). We found these alleles to affect splicing of *sad-1* exactly as our CRISPR mutations ([Figure 3---figure supplements 1](#fig3s1){ref-type="fig"}--[2](#fig3s2){ref-type="fig"}).

Whereas TF mutants result in full skipping of the *sad-1* alternative exon, RBP mutants result in only partial skipping. This provides a probable explanation for not identifying these RBPs in our genetic screen: partial exon skipping leads to dim GFP expression, which is not sufficiently bright to be noticed upon brief visual inspection. We therefore tested whether simultaneous loss of both RBPs recapitulates the full skipping of *sad-1* exon 15 observed in TF mutants. We created *mec-8; mbl-1* double mutants expressing the *sad-1* splicing reporter. These double mutants result in complete loss of *sad-1* exon inclusion in the ALM neuron, recapitulating the splicing phenotype of the single TF mutants ([Figure 3G](#fig3){ref-type="fig"}). These results led us to hypothesize that the TFs identified in our screen exert their effects on *sad-1* splicing by controlling expression of both *mec-8* and *mbl-1*.

TFs affecting *sad-1* splicing are required for RBP expression in the ALM neuron {#s2-4}
--------------------------------------------------------------------------------

To examine whether the neuronal TFs alter expression of *mec-8* and *mbl-1* RBPs in the ALM neuron, we created reporter lines for each RBP. To this end, each RBP was C-terminally tagged in a fosmid containing large regions of surrounding genomic context ([@bib32]; [@bib38]) ([Figure 4A--E](#fig4){ref-type="fig"}). Compared to traditional transgenic reporters, fosmids are more likely to contain all regulatory information needed to drive normal expression of the gene in question. This is demonstrated in the case of the *mec-8* RBP. The classical *mec-8::GFP* promoter fusion drives expression in a number of cells, but not in the ALM neuron ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) ([@bib37]). On the other hand, we detected expression of the *mec-8* fosmid reporter in many of the same cells, both neuronal and non-neuronal, plus strong expression in the ALM neuron ([Figure 4A--B](#fig4){ref-type="fig"}). A similar fosmid reporter for *mbl-1* likewise exhibits expression in the ALM neuron, as well as many other neurons in the nervous system ([Figure 4D](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). This is in line with previous reports on *mbl-1* expression ([@bib38]).

![Neuronal TFs establish expression of both *mec-8* and *mbl-1* to mediate splicing of *sad-1* in ALM neurons.\
(**A--B**) A *mec-8* translational GFP fosmid reporter reveals strong expression in ALM neuron (strong expression in 28/31 = 90% of animals inspected). (**C**) In a *mec-3* TF mutant, *mec-8* expression is absent specifically in ALM (no detectable expression in 43/50 = 86%, dim expression in 7/50 = 14% of animals inspected). (**D**) *mbl-1* translational RFP fosmid reporter is expressed in ALM neuron (strong expression in 19/20 = 95% of animals inspected). (**E**) In a *mec-3* mutant, *mbl-1* expression is absent specifically in ALM (no detectable expression in 19/21 = 90%, dim expression in 2/21 = 10% of animals inspected). (**F--G**) Aberrant splicing of *sad-1* in *alr-1* TF mutants is partially rescued by over-expression of either *mec-8* (6/6 animals examined) or *mbl-1* (6/7 animals examined) RBPs (**H--I**). Scale bar represents 10 µm.](elife-46726-fig4){#fig4}

We tested expression of our reporters in the context of a *mec-3* mutant to determine whether expression of *mec-8* and *mbl-1* in ALM neurons depends on the TF cascade uncovered in our screen. The *mec-3* TF is expressed only in touch neurons, and therefore we would expect *mec-3* mutants to affect RBP expression only in the touch neurons. Indeed, in *mec-3* mutants, expression of both *mec-8* and *mbl-1* RBPs are abolished in the ALM neuron, while expression in the surrounding neurons and tissues remains unchanged ([Figure 4B--E](#fig4){ref-type="fig"}). Together these results indicate that the expression of *mec-8* and *mbl-1* RBPs are under the control of neuron subtype-specific TFs.

To examine whether *mec-8* and *mbl-1* RBPs might be under direct transcriptional control by one or more of the TFs, we used existing ChIP data for ALR-1 ([@bib25]), in vitro derived consensus binding motifs for UNC-86 ([@bib42]), and a previously-defined UNC-86/MEC-3 heterodimer binding motif ([@bib35]; [@bib43]). We did not find conserved UNC-86 binding motifs or an UNC-86/MEC-3 heterodimer binding motif in the promoters for *mec-8* or *mbl-1*, but did find ALR-1 ChIP peaks in both promoters ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). This data suggests that *alr-1* may directly control transcription of *mec-8* and *mbl-1* RBPs.

TFs affect *sad-1* splicing by controlling RBP expression in the ALM neuron {#s2-5}
---------------------------------------------------------------------------

The observations that (1) *mec-8; mbl-1* RBP double mutants recapitulate the phenotype of the TF mutants, and (2) the TFs are necessary for expression of both RBPs in the ALM neuron, together suggest that the splicing defects in the TF mutants are mediated by effects on expression of the two RBPs. Further support for this hypothesis arose indirectly in the course of crossing TF and RBP mutants together. We found that while TF or RBP mutant heterozygotes exhibit normal *sad-1* splicing in the ALM neuron, double heterozygotes (for example *alr-1*/+; *mbl-1*/+, or *mec-3/+; mec-8/+)* exhibit partial exon skipping in ALM, similar to the RBP single mutants ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). Such 'non-allelic non-complementation' is often interpreted to mean that the two genes function in the same complex, or, more likely in this case, function in the same pathway ([@bib45]). This indirect evidence further suggests that the TFs and RBPs affect *sad-1* splicing as part of the same molecular pathway.

If *sad-1* splicing is controlled in a linear pathway as suggested by the above series of experiments, with upstream TFs affecting RBP expression in the ALM neuron, then over-expressing an RBP in the context of a TF mutant should partially restore splicing in ALM. To test this hypothesis we created a strain over-expressing a *mec-8* transgene specifically in the touch neurons (*pmec-3::mec-8*). When introduced into an *alr-1* mutant, this transgene partially rescues the splicing of *sad-1* in the ALM neuron ([Figure 4F--H](#fig4){ref-type="fig"}). Likewise, over-expression of *mbl-1* in an *alr-1* mutant partially rescues splicing in the ALM neuron ([Figure 4I](#fig4){ref-type="fig"}). These results further support a linear gene regulatory pathway in which neuronal fate-determining TFs control neuron-specific expression of RBPs, which then control alternative splicing of *sad-1* ([Figure 4J](#fig4){ref-type="fig"}).

RBPs directly mediate *sad-1* exon inclusion through interactions with surrounding introns {#s2-6}
------------------------------------------------------------------------------------------

To test whether *mec-8* and *mbl-1* directly affect splicing by binding to the *sad-1* pre-mRNA, we created two-color splicing reporters in which the putative *mec-8* or *mbl-1 cis*-elements are mutated ([Figure 3A](#fig3){ref-type="fig"} and [Figure 5](#fig5){ref-type="fig"}). If the RBPs act directly by binding the *cis*-element, then mutation of the *cis*-element should affect the splicing pattern in a manner resembling the wild-type splicing reporter in the context of the RBP deletion mutant. If the RBPs act indirectly, mutating the *cis-*element should have no effect on the splicing pattern.

![*mbl-1* and *mec-8* affect *sad-1* splicing by direct interaction with *sad-1* introns.\
(**A--B**) Mutation of *mbl-1* consensus sequence in *sad-1* splicing reporter results in aberrant splicing in ALM neurons that phenocopies an *mbl-1* mutant. (**C--E**) Mutation of either *mec-8* binding motif, or both simultaneously, likewise results in aberrant *sad-1* splicing in ALM neurons. ALM splicing phenotypes fully penetrant (n = 25 animals) Scale bar represents 10 µm.](elife-46726-fig5){#fig5}

Mutation of the *mbl-1 cis*-element resulted in ALM neurons with altered *sad-1* splicing in which the exon is partially skipped and partially included ([Figure 5A--B](#fig5){ref-type="fig"}). This recapitulates the phenotype of *mbl-1* null mutations ([Figure 3F](#fig3){ref-type="fig"}), suggesting that *mbl-1* exerts its effects on splicing directly through binding a conserved *cis*-element in the upstream intron.

We identified two consensus *mec-8* binding motifs in conserved regions in the intron downstream of the cassette exon. We therefore created splicing reporters mutant for both *cis*-elements as well as for each element individually. The splicing reporter mutant for both elements recapitulates the splicing phenotype of *mec-8* null mutants ([Figure 5E](#fig5){ref-type="fig"}). Likewise, mutating either *mec-8* binding site in isolation recapitulates a *mec-8* null mutation ([Figure 3E](#fig3){ref-type="fig"} and [Figure 5C--D](#fig5){ref-type="fig"}), suggesting that *mec-8* binding to both *cis*-elements is required for appropriate *sad-1* splicing.

We tested whether mutation of a putative *cis*-element could be rescued by over-expression of its cognate RBP, and found that *cis-*element mutants were not rescued by RBP over-expression ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}), providing further evidence that the RBPs act directly on the *sad-1* pre-mRNA. Together these results indicate that *mec-8* and *mbl-1* RBPs combinatorially ensure *sad-1* exon inclusion in ALM neurons through direct interactions with the neighboring introns.

*sad-1* splicing in other neuron types is controlled through both distinct and overlapping mechanisms {#s2-7}
-----------------------------------------------------------------------------------------------------

Having identified regulatory mechanisms controlling *sad-1* splicing in the ALM neuron, we next wondered whether similar principles apply in other neuron types. Most neurons besides the ALM and BDU neurons express both skipped and included *sad-1* isoforms. This could represent the neuronal 'ground state' of splicing in the absence of cell-specific splicing regulators. On the other hand, our observations that loss of both *mec-8* and *mbl-1* in the ALM neuron results in full exon skipping suggest that the ground state may be complete exon skipping. This hypothesis predicts that other neurons in which *sad-1* is partially included express one or more RBPs mediating exon inclusion.

In the course of examining *sad-1* splicing in ALM neurons, we noticed that *mbl-1* mutants affect *sad-1* splicing not only in ALM, but also in the excitatory cholinergic motor neurons of the ventral nerve cord ([Figure 6A--D](#fig6){ref-type="fig"}). Whereas *mbl-1* mutants cause a change in *sad-1* splicing from full inclusion to partial inclusion in ALM neurons, in excitatory motor neurons *mbl-1* mutants shift from partial inclusion to no inclusion ([Figure 6C--D](#fig6){ref-type="fig"}). On the other hand, the inhibitory motor neurons remain unaffected in *mbl-1* mutants, expressing both the included and skipped isoforms ([Figure 6D](#fig6){ref-type="fig"}, arrowheads). This is consistent with our *mbl-1* gene expression reporter, which reveals expression of *mbl-1* in the excitatory motor neurons, but not in the inhibitory motor neurons ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}).

![*sad-1* splicing in motor neurons of the ventral nerve cord is controlled by *mbl-1* and *msi-1* RBPs.\
(**A--C**) In wild-type worms, *sad-1* is partially included in both excitatory and inhibitory motor neurons. (**D**) In *mbl-1* mutants, exon inclusion is lost in excitatory motor neurons, but remains in inhibitory motor neurons (arrowheads). (**E**) *msi-1* mutants lose exon inclusion in inhibitory motor neurons (arrowheads) but not in excitatory motor neurons. (**F**) *mbl-1; msi-1* double mutants lose exon inclusion in all motor neurons in the ventral nerve cord. Splicing phenotypes in ventral nerve cord invariant (n = 15 animals) (**G**) Conservation scores (determined as in [Figure 3A](#fig3){ref-type="fig"}) in the introns surrounding *sad-1* exon 15. Number one indicates consensus binding motifs for *msi-1*. (**H**) *cis-*elements matching consensus binding motifs for *msi-1.* Asterisk indicates anterior-posterior position of ALM neuron as anatomical reference. Splicing phenotypes fully penetrant (n = 50 animals). Scale bar represents 10 µm.](elife-46726-fig6){#fig6}

We did not detect *mec-8* expression in motor neurons of the ventral nerve cord, and *mec-8* mutants had no effect on splicing of *sad-1* in motor neurons ([Figures 3E](#fig3){ref-type="fig"} and [4B](#fig4){ref-type="fig"}). It therefore seems that in neurons expressing *mbl-1* such as excitatory motor neurons, the presence of *mbl-1* mediates partial exon inclusion. In neurons expressing both *mbl-1* and *mec-8* such as ALM touch neurons, the two RBPs together mediate full inclusion.

In *mbl-1* mutants, *sad-1* exon inclusion is lost in excitatory neurons but remains in inhibitory motor neurons. We therefore wondered whether there was an additional RBP expressed in inhibitory motor neurons mediating *sad-1* inclusion. *mec-8* was ruled out because it is not expressed in inhibitory motor neurons and does not affect *sad-1* splicing in the nerve cord. On the other hand, the RBP *msi-1*/Musashi has been reported to be expressed in inhibitory but not excitatory neurons of the nerve cord ([@bib44]), which is a mutually exclusive pattern with *mbl-1*. We therefore tested *msi-1* as a candidate for the RBP mediating *sad-1* exon inclusion in the inhibitory motor neurons. We generated a *msi-1* deletion mutant, which shows loss of *sad-1* inclusion specifically in the inhibitory motor neurons ([Figure 6E](#fig6){ref-type="fig"}). Furthermore, *msi-1; mbl-1* double mutants result in complete loss of exon inclusion in the ventral nerve cord ([Figure 6F](#fig6){ref-type="fig"}). These results indicate that *mbl-1* and *msi-1* act in distinct cell types to achieve partial *sad-1* exon inclusion throughout the ventral nerve cord.

We suspect that *msi-1*, like *mbl-1* and *mec-8*, directly affects *sad-1* splicing by binding in the intronic regions surrounding the alternative exon. in vitro experiments have identified a UAG motif ([Figure 6H](#fig6){ref-type="fig"}) ([@bib34]), usually in bipartite form (*e.g.* UAGNNUAG) ([@bib7]), as the consensus binding motif for *msi-1*. There is a conserved bipartite UAG motif in the intron downstream of the *sad-1* cassette exon ([Figure 6G--H](#fig6){ref-type="fig"}), and we hypothesize that *msi-1* binds there to mediate exon inclusion in inhibitory motor neurons.

Phenotypic convergence of splicing regulation in diverse neuron types {#s2-8}
---------------------------------------------------------------------

Together the results from three different neuronal cell types (ALM neuron, excitatory motor neurons, and inhibitory motor neurons) constitute an example of 'phenotypic convergence,' in which phenotypic similarity between cells is generated by distinct molecular mechanisms. Substantial evidence of such phenotypic convergence exists for TFs controlling neuronal properties in worms and flies ([@bib8]; [@bib18]; [@bib31]). Our results now extend this principle to RBPs and their control of alternative splicing, revealing phenotypic convergence in which similar splicing patterns (*i.e. sad-1* exon inclusion) are generated in various neurons by diverse RBPs acting in specific neuronal subtypes ([Figure 7](#fig7){ref-type="fig"}).

![Phenotypic convergence at the level of splicing regulation.\
Different RBPs act in different neuron types to carry out the common function of mediating *sad-1* exon inclusion.](elife-46726-fig7){#fig7}

To further examine this principle, we tested whether ectopic expression of an RBP in a neuron type in which it is not normally expressed would be sufficient to alter *sad-1* splicing in that neuron. We expressed *mec-8* in excitatory motor neurons (where normally only *mbl-1* is expressed) and found that *mec-8* expression is sufficient to alter *sad-1* splicing patterns from partial inclusion to full inclusion specifically in the excitatory motor neurons ([Figure 6---figure supplement 2A](#fig6s2){ref-type="fig"}). Similarly, *mbl-1* expression in inhibitory motor neurons (where normally only *msi-1* is expressed) results in full exon inclusion \[[Figure 6---figure supplement 2A](#fig6s2){ref-type="fig"}\]).

Finally, we asked whether phenotypic convergence occurs simultaneously at multiple levels (TFs and RBPs) with regard to *sad-1* splicing. To do so we examined mutants for the TF *unc-3*, which controls the fate of excitatory motor neurons in the ventral nerve cord ([@bib19]), analogous to ALM cell fate determination by *unc-86/mec-3/alr-1*. In *unc-3* mutants, *sad-1* exon inclusion is lost in excitatory motor neurons, similar to *mbl-1* RBP mutants ([Figure 6D](#fig6){ref-type="fig"}, [Figure 6---figure supplement 2B](#fig6s2){ref-type="fig"}). However, whereas *unc-86/mec-3/alr-1* mutants exhibit completely-penetrant loss of *sad-1* exon inclusion, *unc-3* mutants exhibit partially-penetrant defects, ranging from moderate to complete loss of *sad-1* inclusion in excitatory motor neurons. Similarly, loss of *unc-3* results in partially-penetrant defects in *mbl-1* expression ([Figure 6---figure supplement 2C](#fig6s2){ref-type="fig"}).

Together these results demonstrate that phenotypic convergence among different neuron types occurs simultaneously at multiple layers of gene regulation: different TFs (*e.g. mec-3* and *unc-3*) specify expression of different RBP complements (*e.g. mbl-1* and *mec-8*) which have a common function of mediating *sad-1* exon inclusion.

Discussion {#s3}
==========

Neuron-specific regulation of *sad-1* splicing {#s3-1}
----------------------------------------------

In this study we find that *sad-1* splicing undergoes precise regulation in numerous neuronal types. Although ALM and BDU neurons are sister cells, express many of the same genes, and share a number of cell-specific TFs, they have opposing patterns of *sad-1* splicing. This highlights the fact that post-transcriptional control can further diversify attributes of single cells on top of the more well-known role of transcriptional control.

Our results demonstrate that *sad-1* splicing is regulated according to a combinatorial RBP code, with different splicing outcomes depending on whether a cell expresses zero, one, or two neuron-specific RBPs ([Figure 7](#fig7){ref-type="fig"}).This suggests that the 'default' outcome of *sad-1* splicing is full skipping of the cassette exon, as observed in the BDU neuron which does not express any of the *sad-1*-regulating RBPs. Only cells with at least one RBP mediating exon inclusion express *sad-1* included isoforms. Cells with multiple such RBPs (*e.g.* the ALM neuron) express only the included isoform.

In previous work we found that alternative splicing of the kinase *unc-16/* JIP3 in motor neurons is likewise controlled by a pair of RNA binding proteins ([@bib26]). However, *unc-16* splicing and *sad-1* splicing in motor neurons are regulated by distinct pairs of RBPs. Whereas *sad-1* splicing in motor neurons is regulated by *mbl-1* and *msi-1* RBPs, *unc-16* is combinatorially regulated by *unc-75* and *exc-7* in motor neurons ([@bib26]). This suggests that even within a single neuron type, different splicing events are regulated by different complements of RBPs.

Coordinated splicing regulation across layers of gene expression {#s3-2}
----------------------------------------------------------------

The importance of TFs controlling gene expression networks in single neurons is well established, and the importance of RBPs controlling post-transcriptional networks in single cells is gaining wider appreciation ([@bib29]; [@bib26]; [@bib36]; [@bib41]). How these two modes of regulation might interact remains understudied. Here we show that the two modes of regulation interact in a traditional linear type of pathway. A combination of cell-specific TFs establishes a transcriptional network in a single neuron type. This network includes a specific combination of neuronal RBPs, and the particular combination of RBPs in a given neuron then establish a unique post-transcriptional gene regulatory network in that neuron. Multiple layers of regulatory control can thus increase the diversity of single neuron transcriptomes and fine-tune the properties of individual neurons.

In the present study we have identified a linear pathway in which TFs influence the expression of RBPs, which then influence alternative splicing in single neurons. This adds to a substantial body of literature finding that RBPs can affect the function of specific TFs by modulating their alternative splicing ([@bib3]; [@bib11]; [@bib21]; [@bib33]). In the future it will be interesting to see whether additional regulatory logics exist between TFs and RBPs. Single-neuron TF combinations have been identified with a variety of feedback and feedforward mechanisms resulting in interesting regulatory properties ([@bib23]), and in principle TFs and RBPs could likewise interact in complex ways, leading to an even greater array of diversification strategies ([@bib12]). Together this study highlights the importance of considering neuron-specific 'combinatorial codes' not only from the perspective of TF combinations, but the specific complement of both TFs and RBPs shaping the transcriptome of a given neuron.

Phenotypic convergence at the level of single-neuron splicing {#s3-3}
-------------------------------------------------------------

A theme emerging from recent studies of single-neuron transcriptomes is 'phenotypic convergence,' in which multiple neurons share gene expression similarities, but the regulatory mechanisms by which they do so are distinct in each neuron. For example, in worms, cholinergic neuron cell fate and core cholinergic gene expression properties are controlled by different combinations of TFs in different cholinergic neuron sub-types ([@bib31]). This is also the case for other neuron types in *C. elegans* ([@bib8]). More recently, phenotypic convergence has been reported for TFs in neurons of the *Drosophila* optic lobe ([@bib18]), indicating that phenotypic convergence mediated by TFs is a widespread phenomenon.

We now extend this principle of phenotypic convergence to the regulation of splicing by RBPs as well. *sad-1* exon inclusion is mediated in various neuron types, with a unique complement of RBPs responsible for exon inclusion in each specific type that we have studied (ALM neuron, inhibitory motor neurons, and excitatory motor neurons; [Figure 7](#fig7){ref-type="fig"}). This likely represents phenotypic convergence on multiple levels, as the RBPs regulating splicing are different in each neuron, and the TFs regulating RBP expression are likewise different in each neuron. Each of these levels coordinately converges upon appropriate splicing of *sad-1* in each neuron type. Additional neuron types with similar *sad-1* splicing patterns (see [Figure 1](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) may represent additional examples of phenotypic convergence whose underlying mechanisms remain unexplored.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\           Designation                                              Source or reference            Identifiers   Additional\
  (species) or resource                                                                                                         information
  ----------------------- -------------------------------------------------------- ------------------------------ ------------- ------------------------------
  Strain                  unc-86(csb9)                                             This study                     JAC401        Norris Lab. SMU. Dallas, TX.

  Strain                  mec-3(csb10)                                             This study                     JAC402        Norris Lab. SMU. Dallas, TX.

  Strain                  alr-1(csb11)                                             This study                     JAC403        Norris Lab. SMU. Dallas, TX.

  Strain                  unc-86(e1416)                                            CGC, University of Minnesota   CB1416        

  Strain                  mec-3(e1338)                                             CGC, University of Minnesota   CB1338        

  Strain                  alr-1(oy42)                                              CGC, University of Minnesota   PY1598        

  Strain                  mec-8(e398)                                              CGC, University of Minnesota   CB398         

  Strain                  mec-8(csb22)                                             This studdy                    JAC626        Norris Lab. SMU. Dallas, TX.

  Strain                  mbl-1(csb31)                                             This study                     JAC635        Norris Lab. SMU. Dallas, TX.

  Strain                  mbl-1(wy560)                                             CGC, University of Minnesota   JAC002        

  Strain                  msi-1(csb24)                                             This study                     JAC628        Norris Lab. SMU. Dallas, TX.

  Strain                  mec-8(csb22); mbl-1(wy560)                               This study                     ADN342        Norris Lab. SMU. Dallas, TX.

  Strain                  mec-8(csb22); mbl-1(csb31)                               This study                     JAC670        Norris Lab. SMU. Dallas, TX.

  Strain                  msi-1(csb24); mbl-1(csb31)                               This study                     ADN257        Norris Lab. SMU. Dallas, TX.

  Strain                  pmec-3::mec-8                                            This study                     ADN431        Norris Lab. SMU. Dallas, TX.

  Strain                  pmec-3::mbl-1                                            This study                     ADN514        Norris Lab. SMU. Dallas, TX.

  Strain                  punc-25::mbl-1                                           This study                     ADN515        Norris Lab. SMU. Dallas, TX.

  Strain                  punc-17::mec-8                                           This study                     ADN505        Norris Lab. SMU. Dallas, TX.

  Strain                  Δmbl-1 *cis*-element *sad-1* splicing reporter           This study                     ADN319        Norris Lab. SMU. Dallas, TX.

  Strain                  Δmec-8\[1\] *cis*-element *sad-1* splicing reporter      This study                     ADN364        Norris Lab. SMU. Dallas, TX.

  Strain                  Δmec-8\[2\] *cis*-element *sad-1* splicing reporter      This study                     ADN377        Norris Lab. SMU. Dallas, TX.

  Strain                  Δmec-8\[both\] *cis*-element *sad-1* splicing reporter   This study                     ADN333        Norris Lab. SMU. Dallas, TX.

  Strain                  *sad-1* splicing reporter                                This study                     JAC017        Norris Lab. SMU. Dallas, TX.

  Strain                  MEC-8::GFP reporter fosmid                               This study                     JAC447        Norris Lab. SMU. Dallas, TX.

  Strain                  MBL-1::RFP reporter fosmid                               This study                     JAC576        Norris Lab. SMU. Dallas, TX.

  Strain                  *pmec-8::GFP*                                            CGC, University of Minnesota   BC11068       

  Strain                  unc-3(e151)                                              CGC, University of Minnesota   CB151         
  ------------------------------------------------------------------------------------------------------------------------------------------------------------

Strain maintenance {#s4-1}
------------------

*C. elegans* were maintained under standard conditions ([@bib2]) at 20°C on nematode growth media (NGM) plates seeded with OP50 *E. coli* bacteria. New transgenic worms were generated by microinjection with 15 ng/μl transgene and 15 ng/μl co-injection marker (either *rgef-1*, *unc-17*, or *unc-25* promoter driving BFP).

Mutant generation and genetic screening {#s4-2}
---------------------------------------

The forward mutagenesis screen was performed on animals harboring the *sad-1* exon 15 splicing reporter with EMS at 47 mM for 4 hr. F~1~s were picked onto new plates, 10 F~1~s per plate. After 3--4 days of growth, F~2~s were screened by eye on the Zeiss Axiozoom.V16 for touch cells appearing in the GFP channel (representing aberrant exon skipping) and were then verified for a concomitant loss of RFP (representing loss of exon inclusion). Such worms were picked individually onto a new plate to verify the phenotype in the F~3~ generation and to establish a clonal population. After outcrossing, strains were subjected to whole-genome resequencing (Illumina, 1 × 75 bp) and potential causative mutations were identified using the CloudMAP workflow on the Galaxy web platform ([@bib24]). A total of approximately 6000 haploid genomes were screened.

Targeted mutant strains were generated using CRISPR/Cas9 as previously described ([@bib4]; [@bib27]), such that the gene of interest is deleted and is replaced with a heterologous GFP reporter under the control of a pharyngeal promoter (pmyo-2) which does not interfere with the visualization of the *sad-1* splicing reporter in the ALM, BDU or ventral nerve cord neurons. Seamless gene replacement was verified by PCR amplification and Sanger sequencing of both junction boundaries.

Microscopy {#s4-3}
----------

Images were obtained with a Zeiss Axio Imager.Z1 and processed in ImageJ.

Generation of splicing reporters {#s4-4}
--------------------------------

*sad-1* minigenes were created using the following primers: Forward 5' GATAAAACTGAAACAACTTCTGC and Reverse 5' GGGGTTGGCGATTTGTATGAGaTAGC. Restriction sites were appended to both the forward primer (XhoI) and reverse (NotI) primers to facilitate cloning into a Gateway-compatible vector as previously described ([@bib26]). The reporter was then cloned downstream of a pan-neuronal *rgef-1* promoter, as endogenous *sad-1* has been detected broadly throughout the nervous system ([@bib5]). Mutant versions of the splicing reporter were synthesized de novo then cut with XhoI and NotI and cloned as above.

Some strains were provided by the Caenorhabditis Genome Center, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). Other strains were provided by the National BioResource Project (Tokyo).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Splicing in a single neuron is coordinately controlled by RNA binding proteins and transcription factors\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and James Manley as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Hidehito Kuroyanagi (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In this paper, the authors use an in vivo fluorescent splicing reporter to study cell-specific post-translational regulation. Making use of the genetic amenability of *C. elegans*, the authors employ forward genetic screens and candidate approaches to identify the genes required for cell-specific splicing events. Through the characterization of the complex splicing patterns of the conserved neuronal kinase *sad-1*, the authors elegantly reveal that neuronal identity regulator transcription factors and RNA binding proteins are required for *sad-1* exon inclusion. Neuron-type specific expression of RBPs is controlled by these transcription factors, and RBPs directly interact with *sad-1* introns. Moreover, the authors demonstrate that *sad-1* splicing in different neuron-types is controlled by different RBPs, revealing phenotypic convergence at the level of single-neuron splicing.

The authors employed CRISPR-Cas9 mediated genome editing and a smart splicing reporter to support their conclusions. The overall conclusions on transcriptional control of RBPs and phenotypic convergence appear interesting. However, there is some lack in the depth of analysis, particularly as it pertains to the analysis of the transcription factors. Moreover, there is striking, in fact almost baffling, lack of detail in data/reagent presentation throughout the manuscript. A substantial revision of the paper will allow the authors to better support what appears to be a very interesting finding.

Essential revisions:

1\) There is a concern that the evidence that the three RBPs \"directly\" regulate pre-mRNA splicing of the *sad-1* gene via their respective cis-elements is weak. The conclusion is based on high-throughput in vitro screening for consensus binding sequences of the RBPs (Ray et al., 2013), effects of the RBP mutations on the *sad-1* reporter expression (Figure 3 and Figure 6) and effects of mutations in the putative cis-elements on the reporter expression (Figure 5). Direct and specific binding of recombinant RBPs to the respective RNA sequences in vitro and/or defective responses of the mutant reporters to RBP overexpression need to be provided support the direct regulation; otherwise the possibility that MBL-1 regulating *sad-1* splicing through post-transcriptional regulation of MEC-8 and/or other RBP(s), and vice versa, cannot be excluded. This point is important especially for *mbl-1* and *msi-1* because the manuscript will be the first experimental demonstration that these genes regulate pre-mRNA splicing in *C. elegans*. It is also important to keep in mind that the consensus sequences experimentally identified in Ray et al., 2013 and logos shown in Figure 3, Figure 5 and Figure 6 of the manuscript are for a human orthologue of MBL-1, human and *Drosophila* orthologues of MSI-1 and not those in *C. elegans* (this should be more explicitly stated in the figures).

2\) The common standard for validating that a mutant retrieved from a screen really is the causative mutant is to either rescue or use multiple alleles. The authors do neither. They need to validate the identity of their screen mutants by examining the expression of the *sad-1* splicing reporter on a canonical allele of at least *mec-3*.

3\) It would be appreciated if the authors could extend their concept of TFs controlling splicing patterns by RBPs through testing whether *mbl-1* expression in excitatory neurons -- and hence *sad-1* splicing -- depends on *unc-3*, the excitatory MN \"alter ego\" of *unc-86/mec-3* in the touch neurons. This experiment is very easy to perform and would broaden the concept of cell type-specific TFs controlling cell-type specific RBPs to other neuron types.

4\) Figure 7. The authors discuss that 100% exon inclusion might require multiple RBPs. Alternatively, 100% exon inclusion might require RBP binding on both sides of the exon in question (e.g. in ALM, *mbl-1* seems to bind upstream of *sad-1* exon 15, while *mec-8* seems to bind downstream). This hypothesis can be easily tested by *mec-8* overexpression in cholinergic MN (mirroring ALM neurons), or by *mbl-1* overexpression in GABAergic MN (preferable since it is a new untested scenario).

5\) Generally, there is a baffling, if not troubling lack of any detail in describing and properly quantifying data and of description of reagents. This pervades the entire manuscript. Below a number of examples (in no order of importance):

a\) In panels Figure 2C-F, Figure 3D-G, Figure 4B-E, Figure 4F-I, Figure 5, Figure 6C-F, Figure 3---figure supplement 2, Figure 4---figure supplement 1, Figure 4---figure supplement 2, and Figure 4---figure supplement 3 the authors do not provide any quantification to support their data (incl. the number of animals examined). It is unclear whether in all cases there is a fully penetrant phenotype. In cases of a fully penetrant phenotype (e.g. Figure 2C-F?), a simple explanation on the legend accompanied with the number of animals where the phenotype was observed will suffice. It is odd that the authors do not appear to be familiar with the standards in the field. In the case of partial exon skipping phenotypes, it is unclear to this reviewer whether all animals show always same levels of GFP and RFP expression in ALM (e.g. in the double heterozygotes). For variable phenotypes, a qualitative quantification (%dark/dim/bright red/green), or any other means of quantification deemed appropriate by the authors, is required.

b\) There\'s no description of the splicing reporter. Is the reporter driven by its own promoter or the endogenous promoter? They refer to a previous paper (Norris, 2014) which states vectors that drove expression of each reporter pan-neuronally, or with endogenous promoter sequences

c\) The authors generate a number of deletion mutants for different genes using CRISPR/Cas9 (*mec-8, mbl-1*, not specified for *msi-1*) however, they don\'t provide any description on the nature of the molecular lesion other than a brief reference to a previous paper. A schematic of the mutations should be provided in the respective main figures or in a supplementary figure, with a more detailed explanation on the legends or in the Materials and methods section.

d\) There is no list of the strains used on this study as a supplementary file. For example, which is the allele name of the new deletions?

e\) Authors need to describe how new transgenic strains were generated (DNA mix concentrations, simple or complex arrays, etc.).

f\) These newly generated deletion mutants via CRISPR/Cas9 seem to include a GFP reporter construct, subsection "Mutant generation and genetic screening": \"the gene of interest is deleted and is replaced with a heterologous GFP reporter construct\". However, authors use fosmid reporters to analyze *mec-8* and *mbl-1* expression (Figure 4). Do these new *mbl-1* and *mec-8* deletion alleles recapitulate *mbl-1* and *mec-8* expression through the GFP reporter? In that case, does this GFP expression interfere with the analysis of the *sad-1* splicing reporter green fluorescence?

g\) Subsection "RBPs directly mediate *sad-1* exon inclusion through interactions with surrounding introns", \"Most neurons besides the ALM and BDU neurons express both skipped and included *sad-1* isoforms\". Attending to the merge provided in Figure 1C, several neurons in the head and tail seem to exclude exon 15. It will be very informative if authors provide a more detailed expression data of their splicing reporter on Figure 1. For example, just a gross quantification of the% of neurons with included/excluded/both in the head, tail, major ganglia, etc., will greatly help the authors to better illustrate the splicing event under study.

h\) Figure 4A-E, *mec-8* and *mbl-1* expression. Was *mec-8* fosmid reporter expression detected in other neurons? Also, authors mention that the *mbl-1* fosmid reporter is expressed in \"most other neurons\" (subsection "TFs affecting *sad-1* splicing are required for RBP expression in the ALM neuron", Figure 4D). To support their point, authors could show whole worm images or high magnification images of specific regions (head, tail, etc.). This needs to be properly documented with an image.

10.7554/eLife.46726.023

Author response

> Essential revisions:

*1) There is a concern that the evidence that the three RBPs \"directly\" regulate pre-mRNA splicing of the sad-1 gene via their respective cis-elements is weak. The conclusion is based on high-throughput* in vitro *screening for consensus binding sequences of the RBPs (Ray et al., 2013), effects of the RBP mutations on the sad-1 reporter expression (Figure 3 and Figure 6) and effects of mutations in the putative cis-elements on the reporter expression (Figure 5). Direct and specific binding of recombinant RBPs to the respective RNA sequences* in vitro *and/or defective responses of the mutant reporters to RBP overexpression need to be provided support the direct regulation; otherwise the possibility that MBL-1 regulating sad-1 splicing through post-transcriptional regulation of MEC-8 and/or other RBP(s), and vice versa, can not be excluded. This point is important especially for mbl-1 and msi-1 because the manuscript will be the first experimental demonstration that these genes regulate pre-mRNA splicing in C. elegans. It is also important to keep in mind that the consensus sequences experimentally identified in Ray et al., 2013 and logos shown in Figure 3, Figure 5 and Figure 6 of the manuscript are for a human orthologue of MBL-1, human and Drosophila orthologues of MSI-1 and not those in C. elegans (this should be more explicitly stated in the figures).*

We have performed the suggested in vivoexperiments, subjecting mutant reporters to RBP overexpression, and found that the defective splicing pattern remains unchanged (subsection "RBPs directly mediate *sad-1* exon inclusion through interactions with surrounding introns" and Figure 5---figure supplement 1). We also now explicitly state in the figures which species provided each recombinant RBP for generation of in vitrobinding motifs.

> 2\) The common standard for validating that a mutant retrieved from a screen really is the causative mutant is to either rescue or use multiple alleles. The authors do neither. They need to validate the identity of their screen mutants by examining the expression of the sad-1 splicing reporter on a canonical allele of at least mec-3.

We thank the reviewers for pointing out this oversight. We have remedied the error, displaying canonical alleles for each of the TFs identified in our screen in Figure 2 (with allele designations in legend), and alleles identified from our screen in Figure 2---figure supplement 1.

> 3\) It would be appreciated if the authors could extend their concept of TFs controlling splicing patterns by RBPs through testing whether mbl-1 expression in excitatory neurons -- and hence sad-1 splicing -- depends on unc-3, the excitatory MN \"alter ego\" of unc-86/mec-3 in the touch neurons. This experiment is very easy to perform and would broaden the concept of cell type-specific TFs controlling cell-type specific RBPs to other neuron types.

These experiments have been performed, and support the general concept of TFs controlling alternative splicing via RBP expression (Figure 6---figure supplement 2). One unique aspect we have noted is that with *unc-3* mutants and excitatory motor neurons the phenotypes seem to be less penetrant than the fully-penetrant defects in *unc-86/mec-3/alr-1* mutants (discussed in the Discussion section).

> 4\) Figure 7. The authors discuss that 100% exon inclusion might require multiple RBPs. Alternatively, 100% exon inclusion might require RBP binding on both sides of the exon in question (e.g. in ALM, mbl-1 seems to bind upstream of sad-1 exon 15, while mec-8 seems to bind downstream). This hypothesis can be easily tested by mec-8 overexpression in cholinergic MN (mirroring ALM neurons), or by mbl-1 overexpression in GABAergic MN (preferable since it is a new untested scenario).

Both experiments have been performed (Figure 6---figure supplement 2, and subsection "Phenotypic convergence of splicing regulation in diverse neuron types"), and indeed, ectopic expression of either *mbl-1* or *mec-8* in a neuron type in which they are not normally expressed is sufficient to alter *sad-1* splicing patterns (in both cases changing the neuron's splicing pattern from partial exon inclusion to ALM-like full inclusion).

> 5\) Generally, there is a baffling, if not troubling lack of any detail in describing and properly quantifying data and of description of reagents. This pervades the entire manuscript. Below a number of examples (in no order of importance):
>
> a\) In panels Figure 2C-F, Figure 3D-G, Figure 4B-E, Figure 4F-I, Figure 5, Figure 6C-F, Figure 3---figure supplement 2, Figure 4---figure supplement 1, Figure 4---figure supplement 2, and Figure 4---figure supplement 3 the authors do not provide any quantification to support their data (incl. the number of animals examined). It is unclear whether in all cases there is a fully penetrant phenotype. In cases of a fully penetrant phenotype (e.g. Figure 2C-F?), a simple explanation on the legend accompanied with the number of animals where the phenotype was observed will suffice. It is odd that the authors do not appear to be familiar with the standards in the field. In the case of partial exon skipping phenotypes, it is unclear to this reviewer whether all animals show always same levels of GFP and RFP expression in ALM (e.g. in the double heterozygotes). For variable phenotypes, a qualitative quantification (%dark/dim/bright red/green), or any other means of quantification deemed appropriate by the authors, is required.

We apologize for the lack of various details, including quantification, in the first draft of the manuscript. Quantification has now been added in figure legends for all figures requested, as well as a few additional figures. This quantification demonstrates that most (but not all) conditions result in fully-penetrant and invariant splicing outcomes.

> b\) There\'s no description of the splicing reporter. Is the reporter driven by its own promoter or the endogenous promoter? They refer to a previous paper (Norris, 2014) which states vectors that drove expression of each reporter pan-neuronally, or with endogenous promoter sequences

This has been added in subsection "Microscopy".

> c\) The authors generate a number of deletion mutants for different genes using CRISPR/Cas9 (mec-8, mbl-1, not specified for msi-1) however, they don\'t provide any description on the nature of the molecular lesion other than a brief reference to a previous paper. A schematic of the mutations should be provided in the respective main figures or in a supplementary figure, with a more detailed explanation on the legends or in the Materials and methods section.

This has been added as Figure 3---figure supplement 1

> d\) There is no list of the strains used on this study as a supplementary file. For example, which is the allele name of the new deletions?

This has been added in the Key Resource table at the beginning of the Materials and methods section.

> e\) Authors need to describe how new transgenic strains were generated (DNA mix concentrations, simple or complex arrays, etc.).

We have now included details of our microinjection conditions with DNA concentrations, subsection "Strain maintenance". For all experiments, we generated simple arrays.

> f\) These newly generated deletion mutants via CRISPR/Cas9 seem to include a GFP reporter construct, subsection "Mutant generation and genetic screening": \"the gene of interest is deleted and is replaced with a heterologous GFP reporter construct\". However, authors use fosmid reporters to analyze mec-8 and mbl-1 expression (Figure 4). Do these new mbl-1 and mec-8 deletion alleles recapitulate mbl-1 and mec-8 expression through the GFP reporter? In that case, does this GFP expression interfere with the analysis of the sad-1 splicing reporter green fluorescence?

This has been clarified (subsection "Mutant generation and genetic screening") to explain that the GFP in the CRISPR alleles does not report on the endogenous expression of the targeted gene, but rather uses a heterologous *myo-2* pharyngeal promoter to express GFP, in effect "marking" the deletion allele. Given that the GFP is expressed only in the pharynx, this does not interfere with analysis of the *sad-1* reporter in the ALM of VNC neurons.

> g\) Subsection "RBPs directly mediate sad-1 exon inclusion through interactions with surrounding introns", \"Most neurons besides the ALM and BDU neurons express both skipped and included sad-1 isoforms\". Attending to the merge provided in Figure 1C, several neurons in the head and tail seem to exclude exon 15. It will be very informative if authors provide a more detailed expression data of their splicing reporter on Figure 1. For example, just a gross quantification of the% of neurons with included/excluded/both in the head, tail, major ganglia, etc., will greatly help the authors to better illustrate the splicing event under study.

This has been added in Figure 1---figure supplement 1.

> h\) Figure 4A-E, mec-8 and mbl-1 expression. Was mec-8 fosmid reporter expression detected in other neurons?

We have added text (subsection "TFs affecting *sad-1* splicing are required for RBP expression in the ALM neuron") that *mec-8* expression was observed in other neurons in addition to ALM.

> Also, authors mention that the mbl-1 fosmid reporter is expressed in \"most other neurons\" (subsection "TFs affecting sad-1 splicing are required for RBP expression in the ALM neuron", Figure 4D). To support their point, authors could show whole worm images or high magnification images of specific regions (head, tail, etc.). This needs to be properly documented with an image.

We have added a whole worm image for reference (Figure 4---figure supplement 1).
